Fundz
Free weekly newsletter

Get the free weekly contract digest

The new new contracts, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.

Weekly Digest

New new contracts, summarized for you

Straight to Inbox

No login, no app to check — it comes to you

Contract Trends

See who's moving and how much in your market

No credit card required Weekly contract digest

Harbour BioMed Announces Latest Business Progress and Strategic Partnerships

Feb 14, 2025•over 1 year ago

Contract Type

partnership

WashingtonBiotechnologyTherapeuticsBiopharma

Description

Harbour BioMed has announced its latest business progress and update, highlighting sustained profitability driven by accelerated growth of its unique business model and strategic partnerships with global pharmaceutical and leading biotech companies. The company's strong financial performance reflects confidence in its business outlook and underscores management's view that the current valuation does not fully reflect its intrinsic value.

Company Information

Company

Harbour BioMed

Location

Washington, United States

About

Harbour BioMed is a global biopharmaceutical company committed to the discovery, development, and commercialization of novel antibody therapeutics focusing on oncology and immunology.

Predictive Intelligence
Strategic

ML-powered predictions for Harbour BioMed's next move

Learn about Strategic plan

Agreement Insights

Based on industry data
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.